fda incentives to promote rare disease drug development
Published 2 years ago • 299 plays • Length 3:27Download video MP4
Download video MP3
Similar videos
-
3:34
fda incentives to develop pediatric orphan medications
-
1:54
fda providing new grants for natural history studies in rare diseases
-
1:03
navigating expanded access - rare disease drug development series preview
-
2:55
dina zand's work on rare diseases
-
1:50
rare disease drug development education series trailer
-
25:59
fda’s inactive ingredient database (iid) (3of35) complex generics – sep. 25-26, 2019
-
27:51
clinical trials for rare diseases: challenges and opportunities by dr. chris missling, ceo anavex ls
-
13:59
sweet sophia (never underestimate her)
-
1:45
orphan drug, rare pediatric disease, and expedited program designations webinar (10/6)
-
1:29
catherine park's work on rare diseases
-
6:30
rare disease through a different lens
-
7:34:28
fda's rare disease day 2024—dedicated to patients and providers
-
1:29
orphan drug incentives from the fda
-
5:39
challenges of the fda in regards to rare diseases
-
11:19
fda draft guidance: rare disease clinical trials
-
0:50
accelerating rare disease drug development
-
8:12
fda approves bkemv, the first interchangeable biosimilar for two rare diseases!
-
1:01:48
in the spotlight: recent fda updates and guidance for rare disease drug development
-
6:38
fda basics: timothy cote - office of orphan products development
-
30:04
the critical role of 'hyper-targeting' in rare disease drug development
-
57:10
rare diseases are not rare – a training on rare disease resources
-
3:37
what is patient-focused drug development (pfdd)?